Long Mao, Wei Tang, Xiaoying Zhang, Jia Liu, Yile Chen, Yuning Hua, . . . Xiao Xu. (2020). Discovery of a Novel, Selective and Irreversible Inhibitor (Abivertinib) of Mutated EGFR and T790M-induced Resistance for the Treatment of NSCLC. Elsevier.
Chicago Style (17th ed.) CitationLong Mao, et al. Discovery of a Novel, Selective and Irreversible Inhibitor (Abivertinib) of Mutated EGFR and T790M-induced Resistance for the Treatment of NSCLC. Elsevier, 2020.
MLA (9th ed.) CitationLong Mao, et al. Discovery of a Novel, Selective and Irreversible Inhibitor (Abivertinib) of Mutated EGFR and T790M-induced Resistance for the Treatment of NSCLC. Elsevier, 2020.
Warning: These citations may not always be 100% accurate.